In Brief
Refine Search
Biotechnology
UK breakthrough inflammatory disease and immuno-oncology company Mestag Therapeutics and VIB, the leading life science research institute in Flanders. 27 June 2023
Pharmaceutical
Tonix Pharmaceuticals is to buy two marketed acute migraine products from Upsher-Smith Laboratories - Zembrace SymTouch (sumatriptan) and Tosymra (sumatriptan) . 27 June 2023
Pharmaceutical
Japanese pharma major Chugai Pharmaceutical says it will establish a corporate venture capital (CVC) business, under the tentative name “Chugai Venture Fund,” in the Boston area, USA, by the end of 2023 to invest in innovative drug discovery start-up companies to accelerate innovation opportunities centered on innovative new drugs. 27 June 2023
Biotechnology
Dutch gene therapy company uniQure has appointed Walid Abi-Saab as chief medical officer, replacing Ricardo Dolmetsch, who will become president and chief scientific officer. 26 June 2023
Pharmaceutical
Today, the US Food and Drug Administration published a new draft guidance to highlight fundamental considerations to researchers investigating the use of psychedelic drugs for potential treatment of medical conditions, including psychiatric or substance use disorders. 23 June 2023
Biotechnology
Swedish biotech Promore Pharma is engaged in a far-reaching restructuring effort as it faces a challenging financing environment. 22 June 2023
Generics
Indian drugmaker Lupin Limited has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application for tiotropium bromide inhalation powder, 18 mcg/capsule, a generic equivalent of German pharma major Boehringer Ingelheim’s Spiriva HandiHale. 22 June 2023
Pharmaceutical
The US Food and Drug Administration has approved Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) as additions to diet and exercise to improve blood sugar control in children 10 years and older with type 2 diabetes 21 June 2023
Pharmaceutical
Danish diabetes care giant Novo Nordisk has warned that the launch of its weight management drug Wegovy (semaglutide) in most of Europe will be slower than planned and the drug will likely not be sold in developing nations for a very long time, as demand booms in the USA. 21 June 2023
Biotechnology
The first sale of Hemgenix (etranacogene dezaparvovec) has triggered a $100 million milestone payment for the gene therapy’s original developer, uniQure. 20 June 2023
Biotechnology
Tony Hoos, who only took over as head of R&D and medical affairs (RDMA) and chief medical officer (CMO) at Swedish Orphan Biovitrum in April, is to leave the Stockholm-based biotech firm, it has been announced. 19 June 2023
Pharmaceutical
UK pharma major AstraZeneca has drafted plans to break out its China business and list it as a separate company in Hong Kong, or maybe Shanghai, as a way of protecting the company from geopolitical tensions, according to a report by the Financial Times this morning. 19 June 2023
Biotechnology
Danish allergy company ALK Abello has announced Carsten Hellman will step down as chief executive, to be replaced by current Fertin Pharma CEO Peter Halling. 19 June 2023
Pharmaceutical
The Prescription Medicines Code of Practice Authority (PMCPA), a division of the UK’s leading pharmaceutical trade body, has issued notices against a number of drugmakers for breaking the code of practice. 16 June 2023
Pharmaceutical
Danish dermatology specialist LEO Pharma has today announced that its new UK and Ireland operational headquarters will be based at Foundation Park, a new leading business campus in Maidenhead, some 30 miles west of London. 16 June 2023
Biotechnology
Biogen has announced several changes to its board of directors, with Alexander Denner, William Jones and Richard Mulligan opting not to stand for re-election. 15 June 2023
Biotechnology
US immuno-oncology cell therapy company 2seventy bio today announced that the Phase I trial of the PLAT-08 study of SC-DARIC33 in acute myeloid leukemia (AML) has been paused by Seattle Children’s, the company’s partner and the regulatory sponsor of the study. 14 June 2023
Generics
Today, the US Food and Drug Administration published an update to the “List of Off-Patent, Off-Exclusivity Drugs without an Approved Generic” (OPOE list). 13 June 2023
Pharmaceutical
The US District Court for the District of Delaware has issued a decision finding that Japanese drug major Astellas Pharma’s US Patent No 10,842 on Myrbetriq (mirabegron), which expires in March 2030, is invalid, the company confirmed today. 12 June 2023
Pharmaceutical
Australia’s Therapeutic Goods Administration (TGA) has issued five infringement notices totalling A$66,600 ($45,000) to Affinity Corp Australia for the alleged unlawful advertising of medicinal cannabis products. 12 June 2023
Biotechnology
Japanese drugmaker Takeda has launched Fruzaqla (fruquintinib) in its home country. 22 November 2024
Biotechnology
Chinese biopharma CStone Pharmaceuticals has announced a strategic commercial collaboration with Pharmalink Store, a prominent pharmaceutical company based in the United Arab Emirates (UAE). 22 November 2024
Biotechnology
Zhongshan-based biopharma company Akeso will await the verdict of the Chinese medicines regulator on a penpulimab-based combo therapy. 22 November 2024
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Pharmaceutical
Shanghai-based Zai Lab and New York’s Pfizer are to work together on the commercialization of Xacduro (sulbactam-durlobactam) in China. 22 November 2024
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
Biotechnology
California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up focused on innovative, next-generation weight loss therapies. Proceeds from the significant, undisclosed round will support development of the company’s novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. 22 November 2024
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
British pharma major AstraZeneca is facing challenges in its bid to secure full approval for its anticoagulant reversal therapy, Andexxa (andexanet alfa), in the USA. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
Privately-held US biotech Alloy Therapeutics has announced a strategic collaboration and license agreement with Takeda Pharmaceutical. 21 November 2024
Pharmaceutical
Japanese drugmaker Eisai has announced that the amyotrophic lateral sclerosis (ALS) treatment Rozebalamin for Injection (mecobalamin) has been launched in Japan as a treatment for slowing progression of functional impairment in amyotrophic lateral sclerosis. 21 November 2024
Pharmaceutical
Germany's Merck has spent more than 25 years researching and developing solutions for advancing multiple sclerosis (MS) care. 21 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Pharmaceutical
Swiss pharma giant Novartis today announced an upgrade to its mid-term guidance, in advance of its Meet Novartis Management event for investors and analysts in London. 21 November 2024
Biotechnology
The US Food and Drug Administration (FDA) has granted accelerated approval of Ziihera (zanidatamab-hrii) 50mg/mL for injection for intravenous use, say the drug’s developer, Jazz Pharmaceuticals. 21 November 2024
Biotechnology
Eli Lilly is not resting on its laurels when it comes to the fast-growing field of obesity treatments, an area in which it is already a leader. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
Biotechnology
Astellas Pharma has been hit by bad news from the US Food and Drug Administration, which will not currently approve the firm’s request to supplement the label for Izervay (avacincaptad pegol). 21 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze